Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash Flows from Operating Activities:
Net income (loss)	$ 176,108	$ 91,369
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, Depletion and Amortization	75,971	78,301
Deferred income tax provision (benefit)	(4,037)	(1,883)
Inventory Write-down	15,430	0
Net loss (gain) on sales of property and equipment	(2,508)	2,958
Noncash compensation	11,279	9,408
Other Noncash Income (Expense)	(268)	1,383
Excluding the effects of acquisitions, increase (decrease) in cash from:
Increase (Decrease) in Accounts Receivable	(96,429)	(51,653)
Inventory	(10,727)	(31,819)
Proceeds from Sale of Equity Method Investments	0	11,300
Other operating assets	(22,128)	(32,857)
Currency translation effect on working capital, excluding cash	5,820	(6,956)
Current liabilities	(29,080)	18,597
Increase (Decrease) in Other Noncurrent Liabilities	(10,275)	(2,011)
Increase (Decrease) in Other Noncurrent Assets	(11,424)	0
Total adjustments to net income (loss)	(78,376)	(16,532)
Net Cash Provided by Operating Activities	97,732	74,837
Cash Flows from Investing Activities:
Payment for (Proceeds from) Other Investing Activity	1,999	2,315
Purchases of property and equipment	(80,575)	(73,262)
Payments to Acquire Debt Securities, Available-for-Sale	0	(7,000)
Distributions of capital from unconsolidated affiliates	2,004	3,182
Dispositions of property and equipment	8,054	217
Net Cash Provided by (Used in) Investing Activities	(68,518)	(63,248)
Payments to Acquire Debt Securities, Available-for-Sale	0	7,000
Cash Flows from Financing Activities:
Payment, Tax Withholding, Share-Based Payment Arrangement	(5,475)	(7,012)
Payments for Repurchase of Common Stock	(30,218)	(9,990)
Other financing activities	0	(111)
Net Cash Provided by (Used in) Financing Activities	(35,693)	(17,113)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	14,955	(4,184)
Net Increase (Decrease) in Cash and Cash Equivalents	8,476	(9,708)
Cash and Cash Equivalents—Beginning of Period	497,516	461,566
Cash and Cash Equivalents—End of Period	$ 505,992	$ 451,858